From Passion Health Primary Care – Trusted, Patient-Centered Care
Today’s health care update covers key developments in pediatric migraine treatment, COVID-19 trends, and the ongoing measles outbreak in Texas. With Ajovy newly approved for children, rising COVID cases nationwide, and continued viral detection in Austin wastewater, providers should remain alert and proactive. These updates reflect our commitment to timely, patient-centered care at Passion Health.
🇺🇸 National Updates
✅ FDA Approves Ajovy for Migraine Prevention in Children
The FDA has approved Teva’s Ajovy (fremanezumab), the first injectable preventive migraine therapy for children aged 6+ who weigh at least 45 kg. Monthly injections are well-tolerated; most side effects are mild injection-site reactions Texas .
✅ COVID Cases Rising: Booster Access Limited to Seniors & High-Risk
COVID-19 infections are climbing nationally amid immune-evasive variants. Updated booster eligibility now limited to those 65+ or with serious health conditions. Vaccination rates remain low among children and younger adults .
🏥 Texas Updates
✅ Measles Outbreak Remains at ~762 Cases
Texas has 762 confirmed measles cases since January, with fewer than ten currently infectious. Hospitalizations total 99, including two child deaths. Travis County surveillance still finds measles virus in wastewater despite few clinical cases .
✅ NB.1.8.1 (“Nimbus”) COVID Variant Dominant
The NB.1.8.1 variant now drives most Texas COVID cases. Known for causing pronounced sore throat (“razor‑blade” sensation), children show high infection rates though serious illness remains uncommon.
🌍 Global Health Alerts
✅ COVID Transmission Growing in 40 U.S. States
CDC data indicates rising virus spread across 40 states. Although hospitalizations remain moderate, public health experts stress ongoing compliance with masking, testing, and vaccination—especially ahead of autumn waves politico.
✅ (No new global outbreak alerts at this time—continue routine screening and travel history monitoring)
💡 Clinical Tips for Providers
• Discuss Ajovy as an option for eligible pediatric migraine patients.
• Recommend COVID booster shots for those eligible, and promote preventive behaviors amid rising cases.
• Verify and update MMR vaccination status in patients from Texas outbreak zones or before school entry.
• For symptomatic patients, assess for both measles and COVID—including variant exposure risk and travel history.
